glabridin has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, WW; Kim, BJ; Kim, HS; Lee, SK; Suh, KS; Sul, D | 1 |
1 other study(ies) available for glabridin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
Topics: Adaptor Proteins, Signal Transducing; Animals; Bone Resorption; Carbonic Anhydrase II; Cathepsin K; Cell Differentiation; Cells, Cultured; Chloride Channels; CSK Tyrosine-Protein Kinase; Gene Expression Regulation; Isoflavones; MAP Kinase Kinase 7; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mitogen-Activated Protein Kinases; NFATC Transcription Factors; Osteoclasts; Phenols; Phosphatidylinositol 3-Kinases; Phosphoproteins; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fos; RANK Ligand; src-Family Kinases; TNF Receptor-Associated Factor 6; Vacuolar Proton-Translocating ATPases | 2012 |